Turkey could have its own COVID-19 vaccine Turkovac available for use by the end of the year, according to the country's Health Minister Fahrettin Koca.
Our round-up of recent biotech financings is headed by a sizeable $200 million third round for Zenas BioPharma, with Cellectis, Reunion Neuroscience, Karius, Context Thera
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.